In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status ...

A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

When Erin Lazarus started suffering from strange symptoms, doctors told her it was just anxiety. She was 23, completing her ...

Caribou Biosciences, Inc.’s CRBU share price has surged by 5.65%, which has investors questioning if this is right time to ...

Living in areas with lower COI levels was associated with more severe disease presentation and poorer disease control among patients with cSLE.

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after ...

Another month, another list of amazing holidays and long weekends. In May, people observe some of the most significant events ...

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

Despite executing "perfectly," Octagon confronted a “scientific no-go,” CEO Isaac Stoner said in his LinkedIn post announcing ...

("Aurinia" or the "Company") (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder ...

Fate Therapeutics, Inc.’s FATE share price has dipped by 5.20%, which has investors questioning if this is right time to buy.